BioMaxima S.A.
BMX.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.02 | 0.13 | -0.58 | -0.02 |
| FCF Yield | 0.74% | -1.13% | -1.31% | 1.45% |
| EV / EBITDA | 74.98 | 128.75 | 36.67 | 32.73 |
| Quality | ||||
| ROIC | -1.08% | -0.84% | 1.15% | 2.02% |
| Gross Margin | -1.92% | -3.07% | 50.19% | 44.13% |
| Cash Conversion Ratio | -2.48 | 0.50 | -0.81 | 2.24 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.08% | 5.78% | -2.65% | -28.38% |
| Free Cash Flow Growth | 163.66% | 0.00% | -207.21% | 125.15% |
| Safety | ||||
| Net Debt / EBITDA | 14.93 | 26.36 | 8.03 | 7.63 |
| Interest Coverage | -1.88 | -1.89 | 3.32 | 4.81 |
| Efficiency | ||||
| Inventory Turnover | 1.13 | 0.95 | 0.54 | 0.66 |
| Cash Conversion Cycle | 106.66 | 123.31 | 182.99 | 156.33 |